Forreast Intelligence Report
ER-02 Sector Landscape: 2834 - Pharmaceutical Preparations
Generated August 25, 2026· Confidence: moderate· Type: sector_landscape· Forreast Score: 62
ER-02 Generalized Landscape — 2834 - Pharmaceutical Preparations
> Forreast Intelligence · ER-02 Generalized Landscape · 2026-08-25 08:44 UTC
> Scope: sector = 2834 - Pharmaceutical Preparations · Companies in cut: 6 · Random seed: `7`
> Aggregate Forreast Score: 48.0/100 (Moderate)
> 7 Forreast vectors from live `forreast_scores` (gate: ≥6) — PASS
---
1. Scope & Methodology
Scope type: sector
Scope value: 2834 - Pharmaceutical Preparations
Universe: all entities with live `forreast_scores` classified into this scope via `leads.industry` / `leads.country`
Selection: randomized 6-company cut, deterministic seed `7` (reproducible)
Vectors: 7 Forreast vectors per company from live `forreast_scores`
Generated: 2026-08-25 08:44 UTC · Methodology: {'universe_size': 6, 'cut_size': 6, 'selection': 'random.sample with deterministic seed', 'vectors': ['threat_level', 'opportunity_level', 'confidence', 'composite_score', 'regulatory_risk', 'operational_risk', 'reputational_risk'], 'data_sources': ['forreast_scores', 'leads'], 'generator': 'er02_landscape.py'}
2. Company Selection
Celularity Inc — 2834 - Pharmaceutical Preparations · US
ANI PHARMACEUTICALS INC — 2834 - Pharmaceutical Preparations · US
Braveheart Bio, Inc. — 2834 - Pharmaceutical Preparations · US
Coya Therapeutics, Inc. — 2834 - Pharmaceutical Preparations · US
Minerva Neurosciences, Inc. — 2834 - Pharmaceutical Preparations · US
ATOSSA THERAPEUTICS, INC. — 2834 - Pharmaceutical Preparations · US
3. Aggregate Comparison Matrix (7 Forreast Vectors)
| Company | Threat | Oppty | Conf | Composite | Regul. | Oper. | Reput. |
|---|
| Celularity Inc | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
| ANI PHARMACEUTICALS INC | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
| Braveheart Bio, Inc. | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
| Coya Therapeutics, Inc. | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
| Minerva Neurosciences, Inc. | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
| ATOSSA THERAPEUTICS, INC. | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
| Aggregate (n=6) | 30.0 | 30.0 | 90.0 | 48.0 | 0.8 | 0.3 | 0.4 |
4. Aggregate Forreast Vectors
| Vector | Mean | Min | Max |
|---|
| threat_level | 30.0 | 30.0 | 30.0 |
| opportunity_level | 30.0 | 30.0 | 30.0 |
| confidence | 90.0 | 90.0 | 90.0 |
| composite_score | 48.0 | 48.0 | 48.0 |
| regulatory_risk | 0.8 | 0.8 | 0.8 |
| operational_risk | 0.3 | 0.3 | 0.3 |
| reputational_risk | 0.4 | 0.4 | 0.4 |
5. Per-Company Profiles
Celularity Inc
Industry: 2834 - Pharmaceutical Preparations · Country: US
Forreast composite: 48.0/100 (Moderate)
Threat 30.0 · Opportunity 30.0 · Confidence 90.0
Regulatory risk 0.8 · Operational 0.3 · Reputational 0.4
ANI PHARMACEUTICALS INC
Industry: 2834 - Pharmaceutical Preparations · Country: US
Forreast composite: 48.0/100 (Moderate)
Threat 30.0 · Opportunity 30.0 · Confidence 90.0
Regulatory risk 0.8 · Operational 0.3 · Reputational 0.4
Braveheart Bio, Inc.
Industry: 2834 - Pharmaceutical Preparations · Country: US
Forreast composite: 48.0/100 (Moderate)
Threat 30.0 · Opportunity 30.0 · Confidence 90.0
Regulatory risk 0.8 · Operational 0.3 · Reputational 0.4
Coya Therapeutics, Inc.
Industry: 2834 - Pharmaceutical Preparations · Country: US
Forreast composite: 48.0/100 (Moderate)
Threat 30.0 · Opportunity 30.0 · Confidence 90.0
Regulatory risk 0.8 · Operational 0.3 · Reputational 0.4
Minerva Neurosciences, Inc.
Industry: 2834 - Pharmaceutical Preparations · Country: US
Forreast composite: 48.0/100 (Moderate)
Threat 30.0 · Opportunity 30.0 · Confidence 90.0
Regulatory risk 0.8 · Operational 0.3 · Reputational 0.4
ATOSSA THERAPEUTICS, INC.
Industry: 2834 - Pharmaceutical Preparations · Country: US
Forreast composite: 48.0/100 (Moderate)
Threat 30.0 · Opportunity 30.0 · Confidence 90.0
Regulatory risk 0.8 · Operational 0.3 · Reputational 0.4
6. Competitive Positioning
Highest composite score (most exposed): Celularity Inc (48.0)
Lowest composite score (least exposed): ATOSSA THERAPEUTICS, INC. (48.0)
Industry mix: 2834 - Pharmaceutical Preparations (6)
7. Opportunities & Vulnerabilities
Top opportunity: Celularity Inc, ANI PHARMACEUTICALS INC
Top threat exposure: Celularity Inc, ANI PHARMACEUTICALS INC
Sector-level regulatory risk (mean): 0.8 — moderate, routine supervision
8. Data Sources & Appendix
Live `forreast_scores` (mrld_app_db) — 7 vectors per entity
`leads` (mrld_app_db) — SIC industry + country classification
Random seed `7`; selection reproducible by re-running with the same seed
---
Forreast Intelligence · ER-02 Generalized Landscape · Montis Sapientia, Fluminis Vis.
